Retrospective evaluation of prospective data from severely ill patients in need of ICU treatments with COVID-19 regarding to superinfections

Retrospective evaluation of prospective data from severely ill patients in need of ICU treatments with COVID-19 regarding to superinfections - CHIRON

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00024687

Enrollment

2000

Registered

2021-03-17

Start date

2020-12-01

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

U07.1

Interventions

Group 1: Analysis of anonymized patient data from a database created in accordance with the IfSG. 20 locations of the Helios Group. Investigation of the following parameters, among others: age, gender

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: ICU period caused by COVID-19

Exclusion criteria

Exclusion criteria: ICU period is before the positive SARS-CoV-2 test. Case is ongoing at the end of the trial.

Design outcomes

Primary

Measure	Time frame
Detection of superinfections in severely ill patients with COVID-19.	—

Secondary

Measure	Time frame
Impact of bloodstream catheters and ventilation on Superinfections; use of antibacterial therapies.	—

Countries

Germany

Contacts

Public ContactIrit Nachtigall

Helios Klinikum Berlin Buch

irit.nachtigall@helios-gesundheit.de(033631) 7-39 58

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026